Lewy body diseases (Parkinson’s disease and dementia with Lewy bodies) and multiple system atrophy (MSA), collectively known as synucleinopathies, share the neuropathological feature of abnormal α-synuclein (αSyn) species accumulated in the central and peripheral nervous systems.1,2. Here, SNCA is linked to Lewy body dementia.